In addition, some biomarkers are also considered to play an important role in NTD screening during pregnancy, such as maternal serum alpha-fetoprotein (MSAFP) [31] and proprotein convertase subtilisin/kexin type 9 (PCSK9) [32]. This evidence concerns the gene AFP and neural tube defect.